26 Grants (Page 1 of 2)
2011
Targeting the amino terminal gate of human MRP1
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA113384-05), $279,215USD, 07/01/2007 -- 05/31/2012
2010
Targeting the amino terminal gate of human MRP1
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA113384-04), $287,850USD, 07/01/2007 -- 05/31/2012
2009
Targeting the amino terminal gate of human MRP1
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA113384-03), $287,850USD, 07/01/2007 -- 05/31/2012
 
Targeting the oligomerization of human ABCG2
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA120221-04), $208,891USD, 04/18/2006 -- 02/28/2011
2008
Targeting the amino terminal gate of human MRP1
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA113384-02), $287,850USD, 07/01/2007 -- 05/31/2012
 
Targeting the oligomerization of human ABCG2
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA120221-03), $208,891USD, 04/18/2006 -- 02/28/2010
2007
Role of p170 in lung tumorigenesis
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA094961-05), $285,759USD, 09/30/2003 -- 06/30/2009
 
Targeting the amino terminal gate of human MRP1
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA113384-01A2), $287,850USD, 07/01/2007 -- 05/31/2012
 
Targeting the oligomerization of human ABCG2
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA120221-02), $208,891USD, 04/18/2006 -- 02/28/2010
2006
Role of p170 in lung tumorigenesis
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA094961-04), $294,294USD, 09/30/2003 -- 06/30/2008
 
Targeting the oligomerization of human ABCG2
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA120221-01), $215,130USD, 04/18/2006 -- 02/28/2010
2005
Role of p170 in lung tumorigenesis
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA094961-03), $301,376USD, 09/30/2003 -- 06/30/2008
2004
Role of p170 in lung tumorigenesis
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA094961-02), $301,376USD, 09/30/2003 -- 08/31/2008
2003
Role of p170 in lung tumorigenesis
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA094961-01A2), $298,680USD, 09/30/2003 -- 08/31/2008
2001
MECHANISM OF DRUG BINDING TO P-GLYCOPROTEIN
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM059475-04), $222,138USD, 09/01/1998 -- 08/31/2003
 
MOLECULAR BASES OF MULTIDRUG RESISTANCE IN CANCERS
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA064539-08), $243,633USD, 07/01/1994 -- 06/30/2003
2000
MECHANISM OF DRUG BINDING TO P-GLYCOPROTEIN
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM059475-03), $215,756USD, 09/01/1998 -- 08/31/2002
 
MOLECULAR BASES OF MULTIDRUG RESISTANCE IN CANCERS
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA064539-07), $236,538USD, 07/01/1994 -- 06/30/2002
1999
MECHANISM OF DRUG BINDING TO P-GLYCOPROTEIN
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM059475-02), 09/01/1998 -- 08/31/2002
 
MOLECULAR BASES OF MULTIDRUG RESISTANCE IN CANCERS
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA064539-06), 07/01/1994 -- 06/30/2002
1998
MECHANISM OF DRUG BINDING TO P-GLYCOPROTEIN
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1R01GM059475-01), 09/01/1998 -- 08/31/2002
 
MOLECULAR BASES OF P GLYCOPROTEIN TOPOLOGY AND FUNCTION
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R29CA064539-05), 07/01/1994 -- 06/30/1999
1997
MOLECULAR BASES OF P GLYCOPROTEIN TOPOLOGY AND FUNCTION
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA064539-04), 07/01/1994 -- 06/30/1998
1996
MOLECULAR BASES OF P GLYCOPROTEIN TOPOLOGY AND FUNCTION
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA064539-03), 07/01/1994 -- 06/30/1999
1995
MOLECULAR BASES OF P GLYCOPROTEIN TOPOLOGY AND FUNCTION
ZHANG, JIAN-TING
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA064539-02), 07/01/1994 -- 06/30/1999